Why don’t your psychiatric drugs work better?
In 2023 alone, the US National Institutes of Health (NIH) poured $1.25 billion into research studying how mental illness ...
Zacks.com on MSN13h
BMY Buoyed by Recent Regulatory Updates: How to Play the Stock?
Last week, Bristol Myers BMY obtained FDA approval for a label expansion of its blockbuster immuno oncology drug Opdivo ...
kffhealthnews2d
Out Of The Trash Bin: How Cobenfy’s Unusual Journey Could Change Pharma
Bristol Myers Squibb's schizophrenia drug, which received FDA approval last week, took a long and winding road to get there. Three decades ago, Eli Lilly developed the drug's forerunner, xanomeline, ...
Neurology Advisor2d
High MMP9 Predicts Poor Antipsychotic Treatment Response in Schizophrenia
High MMP9 was associated with poor antipsychotic treatment response and changes in white matter density among patients with schizophrenia.
Old Drug Repurposed for Schizophrenia Could Reap Alzheimer’s Windfall
Bristol-Myers’ newly approved schizophrenia treatment might be coming full circle.
FiercePharma3d
For Bristol Myers Squibb's newly approved schizophrenia drug, what a long, strange trip it's been
Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...
Yale Daily News3d
Yale doctors weigh in on the first FDA-approved schizophrenia drug in nearly 30 years
For the first time in nearly 30 years, the U.S. Food and Drug Administration has approved a new drug treating schizophrenia, ...
Neos Kosmos5d
The Greek professor who spearheaded a novel drug for schizophrenia
Christopoulos, Dean of the Faculty of Pharmaceutical Sciences at Monash University, is at the centre of a significant ...
As America’s Marijuana Use Grows, So Do the Harms
The drug, legal in much of the country, is widely seen as nonaddictive and safe. For some users, these assumptions are ...
Neurology Advisor6d
Cobenfy Approved for Adult Patients with Schizophrenia
The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride) for the treatment of adults with schizophrenia.
Chemistry World6d
US approves schizophrenia drug with new mode of action
The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...